Skip to main content
Signal8

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

$MLSSPress releaseMay 7, 2026, 8:30 AM ETRead the release

Milestone Scientific provided an update on its CompuFlo business, reporting active procedures and case submissions across multiple MAC jurisdictions and commercial payers following the February launch of its Advisor Program. The company is expanding its national sales footprint and collaborating with academic institutions like the University of Texas and Kansas to support clinical validation and broader acceptance.

Key figures

Cpt code
0777T

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    MLSS: Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption — AI Analysis | Signal8